Discussion
breast cancer
BREAST CANCER
Successful completion of this trial and positive results of the primary hypothesis will demonstrate that DIBH with AV biofeedback can be achieved using a simple device without the need for an in-room installation. The ease of use of the Breathe Well device should encourage clinical adoption of this technique to maximise the number of patients who can benefit from DIBH. From a patient perspective, access to a system offering biofeedback allows patients to be active participants in their treatments.In addition to performing DIBH for left-sided breast cancer patients, a possible future pathway is to investigate the potential of Breathe Well for patients treated in the prone position and for right-sided breast cancer patients, where a reduction in lung dose can be achieved [